Valirx - Overview

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

Registrars: Capita Registrars

Key Personnel

CEO: Suzanne Dilly
CFO: Gerald Desler
Non-Executive Director: Martin Lampshire, Adrian de Courcey
Non-Executive Chairman: Kevin Cox
Non-Executive Director & Chairman: Martin Gouldstone

Contact Details

Address: Stonebridge House, Chelmsford Road, Hatfield Heath, United Kingdom
Phone:
Fax:
Website: http://www.valirx.com
Email:

Listings

ISIN: GB00BLH13C52
Sector: Pharma and Biotech, Pharma and Biotech
Main Indices: FTSE AIM All-Share